This second webinar of the Hot Topics in Lung Cancer series dives into cutting-edge strategies for managing EGFR-positive non-small cell lung cancer (NSCLC). Join us to explore the latest therapeutic advancements and emerging options for EGFR-targeted. Attendees will gain a deeper understanding of the mechanisms of action of EGFR inhibitors through an engaging whiteboard animation, providing a clear view of how these therapies target EGFR mutations. The session will conclude with expert discussions on integrating EGFR-targeted treatments into clinical practice to optimize patient outcomes.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/evaluating-emerging-evidence-novel-treatment-approaches-egfr-positive-nsclc
- Start Date: 2025-04-02 05:00:00
- End Date: 2025-04-02 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: astrazeneca-pharmaceuticals - Amount: 0.0 - Is Kind Support: False Source: daiichi-sankyo,-inc - Amount: 0.0 - Is Kind Support: False Source: lilly-usa-llc - Amount: 0.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest